Yutaka Niihara
Algemeen Directeur bij EMI Holding, Inc.
Vermogen: 1 M $ op 31-05-2024
Actieve functies van Yutaka Niihara
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Algemeen Directeur | 03-05-2011 | - |
| Oprichter | - | - | |
| Directeur/Bestuurslid | 14-07-2011 | 01-05-2015 | |
| Voorzitter | 15-04-2015 | 22-07-2019 | |
| Hoofd Techniek/Wetenschap/O&O | 01-05-2015 | 16-12-2015 | |
| President | 16-12-2015 | 03-02-2016 | |
Hope International Hospice, Inc.
 Hope International Hospice, Inc. Hospital/Nursing ManagementHealth Services Hope International Hospice, Inc. provides services across language-ethnic patient groups, residing within the geographical boundaries of Los Angeles County and parts of Orange County. Its services include medical expertise, nursing care personal care of bathing, grooming and activities of daily living. The company is headquartered in Torrance, CA. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| Financieel Directeur/CFO | - | - | |
| David Geffen School of Medicine | Corporate Officer/Principal | - | - |
| Newfield Nutrition Corp. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| President | - | - | |
| Emausu Medical Japan Co., Ltd. | Directeur/Bestuurslid | - | - |
| Emmaus Medical Europe Ltd. | Directeur/Bestuurslid | - | - |
Loopbaan van Yutaka Niihara
Eerdere bekende functies van Yutaka Niihara
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Directeur/Bestuurslid | 18-08-2023 | 25-09-2023 |
| Algemeen Directeur | 17-07-2019 | 18-08-2023 | |
| Voorzitter | 17-07-2019 | 18-08-2023 | |
| GENEREX BIOTECHNOLOGY CORPORATION | Voorzitter | 25-01-2017 | 12-04-2017 |
Emmaus Medical, Inc.
 Emmaus Medical, Inc. BiotechnologyHealth Technology Emmaus Medical, Inc. engages in the discovery, development and commercialization of treatments and therapies for rare diseases. Its current business is the late-stage development presently in Phase III clinical trials with the FDA of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease. The company was founded on December 20, 2000 and is headquartered in Torrance, CA. | Algemeen Directeur | 20-12-2000 | 01-04-2011 |
| Voorzitter | 20-12-2000 | 01-04-2011 | |
| Oprichter | 08-02-2010 | 01-04-2011 | |
| President | 08-02-2010 | 01-04-2011 | |
| ░░░░░░ ░░ ░░░ ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Yutaka Niihara
| Loma Linda University | Undergraduate Degree |
| Loma Linda University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 11 |
| Japan | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director/Board Member | 7 |
| Chief Executive Officer | 5 |
| Chairman | 4 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TELCON RF PHARMACEUTICAL. INC. | Producer Manufacturing |
| EMMAUS LIFE SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Emmaus Medical, Inc.
Emmaus Medical, Inc. BiotechnologyHealth Technology Emmaus Medical, Inc. engages in the discovery, development and commercialization of treatments and therapies for rare diseases. Its current business is the late-stage development presently in Phase III clinical trials with the FDA of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease. The company was founded on December 20, 2000 and is headquartered in Torrance, CA. | Health Technology |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
Hope International Hospice, Inc.
Hope International Hospice, Inc. Hospital/Nursing ManagementHealth Services Hope International Hospice, Inc. provides services across language-ethnic patient groups, residing within the geographical boundaries of Los Angeles County and parts of Orange County. Its services include medical expertise, nursing care personal care of bathing, grooming and activities of daily living. The company is headquartered in Torrance, CA. | Health Services |
| County of Los Angeles (California) | Government |
| Newfield Nutrition Corp. | |
| Emausu Medical Japan Co., Ltd. | |
| Emmaus Medical Europe Ltd. | |
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
- Beurs
- Insiders
- Yutaka Niihara
- Ervaring
